Research Misconduct in Low- and Middle-Income Countries

1. TavareA (2011) Managing research misconduct: is anyone getting it right? BMJ 343: 2821d.

2. GodleeF, WagerE (2012) Research misconduct in the UK. BMJ 344: d8357.

3. NIH (2009) UnitedHealth and NHLBI Centers of Excellence. Available: http://www.nhlbi.nih.gov/about/globalhealth/centers/index.htm. Accessed 20 August 2012.

4. Public Health Service policies on research misconduct. Final rule. Fed Regist 70: 28369–28400.

5. SmithR (2000) What is research misconduct? J Roy Coll Physicians Edin 30: 4–8.

6. A Consensus Statement on Research Misconduct in the UK, BMJ/COPE High Level Meeting 12 January 2012. Available: http://publicationethics.org/files/A_consensus_statement_on_research_misconduct_in_the_UK. Accessed 17 December 2012.

7. MartinsonBC, AndersonMS, de VriesR (2005) Scientists behaving badly. Nature 435: 737–738.

8. (2010) Singapore Statement on Research Integrity. 2nd World Conference on Research Integrity; 21–24 July 2010; Singapore. Available: http://www.singaporestatement.org/statement.html. Accessed 20 August 2012.

9. FanelliD (2009) How Many scientists fabricate and falsify research? a systematic review and meta-analysis of survey data. PLoS ONE 4 (5) e5738 doi:10.1371/journal.pone.0005738.

10. MarušićA, BošnjakL, JerončićA (2011) A systematic review of research on the meaning, ethics and practices of authorship across scholarly disciplines. PLoS ONE 6 (9) e23477 doi:10.1371/journal.pone.0023477.

11. SteenRG (2011) Retractions in the scientific literature: do authors deliberately commit research fraud? J Med Ethics 37: 113–117.

12. VasconcelosS, LetJ, CostaL, PintoA, SorensonMM (2009) Discussing plagiarism in Latin American science. EMBO Reports 10: 677–682.

13. XinH (2006) Scandals shake Chinese science. Science 312: 1464–1466.

14. ZhangY (2010) Chinese journal finds 31% of submissions plagiarized. Nature 467: 153.

15. ResnikD, ZengW (2010) Research integrity in China: problems and prospects. Dev World Bioeth 10: 164–171.

16. WelchHG, MogielnickiJ (2002) Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer. BMJ 324: 1088–1092.

17. Mukherjee S (2011) The emperor of all maladies. London: Fourth Estate. 592 p.

18. WeissRB, RifkinRM, StewartFM, TheriaultRL, WilliamsLA, et al. (2000) High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study. Lancet 355: 999–1003.

19. McCall-SmithA (2000) What is the legal position? J Roy Coll Surg Edin 30: 22.

20. WhiteC (2005) Suspected research fraud: difficulties of getting at the truth. BMJ 331: 281–288.

21. Expression of concern. BMJ 331: 266.

22. HortonR (2005) Expression of concern: Indo-Mediterranean Diet Heart Study. Lancet 366: 354–356.

23. DeAngelisCD, FontanarosaPB (2008) Retraction: Cheng B-Q, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299: 1669–1677. JAMA 2009 301: 1931.

24. FordP (2009 March 23) China targets an academic culture of cut-and-paste. Christian Science Monitor

25. TanneJH (2010) President Obama apologises to Guatemala over 1940s syphilis study. BMJ 341: c5494.

26. Jones JH (1981) Bad blood: the Tuskegee syphilis experiment. New York City: Free Press.

27. AngellM (1997) The ethics of clinical research in the third world. N Engl J Med 337: 847–849.

28. HalseyNA, SommerA, HendersonDA, BlackRE (1997) Ethics and international research. BMJ 315: 965–966.

29. LenzerJ (2011) Pfizer settles with victims of Nigerian drug trial. BMJ 343: d5268.